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Microglia, the tissue-resident macrophages in the
brain, are damage sensors that react to nearly any
perturbation, including neurodegenerative diseases
such as Alzheimer’s disease (AD). Here, using sin-
gle-cell RNA sequencing, we determined the tran-
scriptome of more than 1,600 individual microglia
cells isolated from the hippocampus of a mouse
model of severe neurodegeneration with AD-like
phenotypes and of control mice at multiple time
points during progression of neurodegeneration. In
this neurodegeneration model, we discovered two
molecularly distinct reactive microglia phenotypes
that are typified by modules of co-regulated type I
and type II interferon response genes, respectively.
Furthermore, our work identified previously unob-
served heterogeneity in the response of microglia
to neurodegeneration, discovered disease stage-
specific microglia cell states, revealed the trajectory
of cellular reprogramming of microglia in response to
neurodegeneration, and uncovered the underlying
transcriptional programs.
INTRODUCTION
Microglia are tissue-resident macrophages in the brain and spi-
nal cord (Prinz and Priller, 2014). They clear apoptotic cells and
are involved in both the elimination and maintenance of synap-
ses for proper neural circuit wiring (Aguzzi et al., 2013). As the
damage sensors for the CNS, microglia have been found to
respond to nearly any CNS perturbation (Fourgeaud et al.,
2016). Indeed, a growing body of evidence based on genome-
wide association studies, transcriptomic, and epigenomic ana-
lyses, as well as experimental evidence in mouse models, impli-
cates immunological mechanisms and their cellular component,366 Cell Reports 21, 366–380, October 10, 2017 ª 2017 The Author(s
This is an open access article under the CC BY-NC-ND license (http://microglia, in the pathogenesis of Alzheimer’s disease (AD) (Gjo-
neska et al., 2015; Mosher and Wyss-Coray, 2014; Neumann
and Daly, 2013; Wang et al., 2015; Zhang et al., 2013). In brain
tissue taken at autopsy from individuals with AD, microglia sur-
round Ab plaques, and their altered morphology indicates that
these cells are responding to challenge (Bouvier et al., 2016;
Heppner et al., 2015).
However, much remains to be learned about the molecular
changes underlying the response of microglia in the AD brain.
In particular, the signal that triggers the initial microglial response
in the brain undergoing neurodegeneration remains to be deter-
mined. Genome-wide transcriptional profiling in microglia has
revealed widespread changes in gene expression in mouse
models of AD (Orre et al., 2014; Wang et al., 2015). However,
ensemble-based approaches that measure gene expression
from bulk populations of microglia cells in AD brains can only
report population averages that may not reflect the response of
individual cells or reveal cell subsets. Furthermore, these studies
characterized the reactive microglia phenotype at only one time
point, late in the progression of neurodegeneration. Therefore,
it remains to be determined how the transcriptional programs in
microglia cells changeover timeas they transition from their initial
homeostatic state in the healthy brain to the reactive phenotypes
seen in the neurodegenerating brain. Because the microglia
phenotype may change drastically over the course of neurode-
generation, tracking with a fine temporal resolution is needed to
capture the full spectrum of microglia cell states.
Here, we use single-cell RNA sequencing to examine the
phenotypic heterogeneity of microglial cells in the healthy brain
and in a mouse model of severe neurodegeneration with AD-
like phenotypes. We identified multiple disease stage-specific
microglia cell states that are almost exclusively observed in the
diseased but not in the healthy brain. We delineate early- versus
late-response gene modules and find that microglia proliferation
is an early response to neuronal insult. We further identify two
distinct reactive microglia phenotypes that arise at a later
stage of neurodegeneration and are typified by modules of
co-regulated type I and type II interferon response genes,).
creativecommons.org/licenses/by-nc-nd/4.0/).
respectively. Our work identifies previously unobserved hetero-
geneity in the response of microglia to neurodegeneration, dis-
covers microglia cell states, reveals the trajectory of cellular
reprogramming of microglia in response to neurodegeneration,
and uncovers the underlying transcriptional programs.
RESULTS
RNA Sequencing Profiling of Single Microglial Cells
Isolated from the Hippocampus
To determine the phenotypic heterogeneity and the transcrip-
tional dynamics of microglia cells during the progression of neu-
rodegeneration, we used the CK-p25 inducible mouse model of
severe neurodegeneration. In CK-p25 mice, the expression of
p25, the calpain cleavage product of Cdk5 activator p35, is un-
der the control of the CamKII promoter and can be switched on
by withdrawing doxycycline from the animal’s diet (Cruz et al.,
2003; Cruz and Tsai, 2004; Fischer et al., 2005; Patrick et al.,
1999). Although the CK-p25 model is not based on any genetic
mutations associated with familial AD, it develops many aspects
of AD-like pathology. A recent study reported that transcrip-
tional profiles from CK-p25 mice and 5XFAD mice, a commonly
used ADmouse model, showmoderate but similar concordance
with human AD brain signatures (Hargis and Blalock, 2017).
Neurodegeneration in CK-p25 mice occurs in a temporally com-
pressed but highly predictable manner (Cruz et al., 2003, 2006;
Fischer et al., 2005). At 2 weeks after p25 induction, CK-p25
mice exhibit DNA damage and increased amyloid-b levels, fol-
lowed by progressive neuronal and synaptic loss with cognitive
impairment, which is severe by 6 weeks of p25 induction (Cruz
et al., 2003, 2006; Fischer et al., 2005; Kim et al., 2008). Addi-
tional AD-like phenotypes found in 6-week induced CK-p25
mice include forebrain atrophy, astrogliosis, aberrant APP pro-
cessing, and hyperphosphorylation of tau (Cruz et al., 2003,
2006). CK-p25 mice also display neurofibrillary tangle-like pa-
thology after 27 weeks of p25 induction (Cruz et al., 2003).
Importantly, as the p25 transgene is strictly expressed only in
excitatory neurons (Figures S1A–S1D), this model permits us
to examine the microglial response to neuronal cell death. We
isolated cells expressing the microglia markers CD11b and
CD45 from the hippocampus of three to four CK-p25 mice
and three CK control littermates at each of the following four
time points during the progression of neurodegeneration: before
p25 induction and 1, 2, and 6 weeks after p25 induction (hence-
forth abbreviated as 0wk, 1wk, 2wk, and 6wk, respectively) (Fig-
ure 1A; Table S1). Individual CD11b-positive and CD45-positive
microglial cells were sorted directly into RNA lysis buffer in 96-
well plates using fluorescence-activated cell sorting (FACS)
(Figure S2). To verify that our sorting protocol resulted in single
cells in each well, we mixed microglia cells from two individually
distinguishable mouse strains (wild-type and a Cx3cr1-
knockout strain expressing TdTomato in microglia) and sorted
single cells into the wells of a 96-well plate. We then measured
the level of Cx3cr1 and TdTomato mRNA in each well using
qPCR. In the large majority of wells, we detected either
Cx3cr1 or TdTomato—but not both—mRNA species, confirm-
ing that the large majority of wells contained a single cell (Fig-
ures S1E–S1G). We prepared a total of 2,183 single-cell RNAsequencing libraries using a modified version of the Smart-
Seq2 protocol (Picelli et al., 2014) and sequenced the libraries
to a depth of 251,353 (median) mapped reads per cell. The
average expression profile across single cells and the matching
population profile were tightly correlated (Figures 1B and S1H),
with an average Pearson product-moment correlation coeffi-
cient (r = 0.86) comparable with that observed in previous
studies (Gaublomme et al., 2015; Shalek et al., 2014). We
removed 498 cells on the basis of quality metrics (see Experi-
mental Procedures), retaining 1,685 cells for further analyses.
To verify that the cells isolated were indeed microglia cells, we
compared the average expression profile of cells isolated from
CK control mice with previously published expression profiles
of specific brain cell types and with the expression profiles of
monocytes and tissue-resident macrophages (Zhang et al.,
2014; Lavin et al., 2014). We found that the average expression
profile of cells isolated from CK control mice clustered with pre-
viously published microglia profiles (Figures S1I and S1J). Com-
parison with the set of 86 microglia signature genes defined by
Butovsky et al. (2014), showed that microglial marker genes
(including Csf1r, Tmem119, P2ry12, Hexb, and Sall1) were ex-
pressed at a relatively uniform level in the large majority of cells.
In contrast, marker genes of peripheral immune cells (Cdc20,
Ccr2, Cd163, and Ly6c1), and natural killer cell and T cell signa-
ture genes (including Zap70, Skap1, and Cd247) (Bezman et al.,
2012) were expressed in only a small subset of the cells (Figures
1C and S1K).
Non-linear Dimensionality Reduction Reveals Multiple
Distinct and Disease Stage-Specific Microglia Cell
States
We analyzed 1,685 transcriptomes of single cells expressing the
microglia markers CD11b and CD45, isolated from the hippo-
campus of 0wk, 1wk, 2wk, and 6wk CK-p25 and CK control lit-
termates. Non-linear dimensionality reduction with t-distributed
stochastic neighbor embedding (t-SNE) followed by density
clustering revealed multiple distinct cell populations (Figure 2A)
(van der Maaten and Hinton, 2008). Cluster 2 predominantly
contained cells isolated from the CK control and 0wk CK-p25
mice (Figures 2B and 2C). Clusters 3 and 7 mainly contained
cells isolated from 1wk CK-p25 mice, and cluster 6 was
composed almost exclusively of cells isolated from 2wk and
6wk CK-p25 mice (Figures 2B and 2C). The large majority of
cells isolated from the CK control mice at all four time points
and from 0wk CK-p25 grouped together in cluster 2 (Figures
2B–2D). Cells isolated from 1wk CK-p25 mice were found in
cluster 2 (42%), cluster 3 (44%), and cluster 7 (10%) (Figures
2C and 2D). By contrast, the large majority of cells isolated
from 2wk (79%) and 6wk (86%) CK-p25 mice grouped together
in cluster 6 (Figures 2C and 2D). We obtained similar results after
using a normalization technique to reduce the effects of con-
founders (Gaublomme et al., 2015) (Figures S3A and S3B),
when we used a different RNA sequencing transcript quantifica-
tion program, RSEM (Figures S3C and S3D), and when we used
the GENECODE release M9 gene annotation (data not shown).
We saw a similar disease stage-specific response of microglia
to neurodegeneration using linear dimensionality reduction
(data not shown) and found comparable results using the SingleCell Reports 21, 366–380, October 10, 2017 367
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Figure 1. Single-Cell RNA Sequencing of Microglia Cells Isolated from the Hippocampus of CK-p25 Mice and CK Control Littermates
(A) Workflow diagram for single-cell RNA sequencing of microglia cells isolated from the hippocampus of CK-p25mice and CK control littermates at four different
time points after p25 induction.
(B) Quality of single-cell RNA sequencing. Scatterplots compare transcript expression (log10[FPKM+1]) between the average of 95 single-cells and a bulk
population of 200 cells. The data from four representative animals are shown.
(C) Heatmap showing the expression level of 86 microglia signature genes (yellow), genes preferentially expressed in peripheral immune cells (black), and natural
killer cell and T cell signature genes (green) across the 1,685 CD11b- and CD45-positive cells analyzed in this study.Cell Consensus Clustering (SC3) algorithm as an alternative
approach to partitioning cellular subpopulations (Kiselev et al.,
2016) (Figures S3E and S3F). Thus, our analysis revealed multi-
ple microglia cell states in the progression of neurodegeneration
that clustered separately frommost of the cells isolated from the
healthy brain (homeostatic microglia): an early-response state
composed mainly of cells from 1wk CK-p25 mice and a late-
response state composed of the large majority of cells isolated
from 2wk and 6wk CK-p25 mice.368 Cell Reports 21, 366–380, October 10, 2017The t-SNE analysis also revealed clusters 4 and 5 (Fig-
ure 2A), which contained only a small number of cells
(9 and 21 cells, respectively) and expressed peripheral im-
mune cell marker genes at higher levels relative to all other
clusters, suggesting that they represent bone marrow-derived
peripheral immune cells (Table S2). Cluster 8 (Figure 2A)
contained cells that came exclusively from one out of
three biological replicates (Table S3), indicating that it likely
resulted from technical confounders and this cluster was
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Figure 2. Non-linear Dimensionality Reduction
Reveals Multiple Distinct and Disease Stage-
Specific Microglia Cell States
(A) Clustering of 1,685 CD11b and CD45 double-
positive cells isolated from the hippocampus into
eight populations. The t-SNE plot shows a two-
dimensional representation of global gene expression
profile relationships among 1,685 cells.
(B) Pie charts showing the composition of some of the
clusters identified in (A).
(C) Pie charts showing the distribution of each group
of cells indicated across the clusters identified in (A)
(excluding cluster 8). Cells are grouped by genotype
and time point.
(D) t-SNE plots as shown in (A). Cells isolated fromCK
control mice (at all four time points) and cells fromCK-
p25 mice 1, 2, and 6 weeks after p25 induction (0wk,
1wk, 2wk, and 6wk, respectively) are highlighted in
red in individual panels.
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therefore excluded from further analyses (see Experimental
Procedures).
Single-Cell Differential Expression Analysis Reveals
Hundreds of Genes Regulated during Cellular
Reprogramming of Microglia in Response to
Neurodegeneration
Wenext examined howmicroglia respond over time in the neuro-
degenerating brain environment by comparing homeostatic mi-
croglia (cluster 2) with early-response state (clusters 3 and 7)
versus late-response state microglia (cluster 6). We used the sin-
gle-cell differential expression (SCDE) software package
(Kharchenko et al., 2014) to reveal hundreds of significantly up-
and downregulated genes in the early and late-response micro-
glia cell states, compared with homeostatic microglia (Figures
S4A–S4C; Table S4). All future references to up- and downregu-
lated gene expression refer to comparison with homeostatic mi-
croglia cluster 2. Gene Ontology (GO) term enrichment analysis
revealed that cell cycle genes and genes involved in DNA repli-
cation and repair were over-represented among the genes upre-
gulated in the early-response cluster 3 (Figures 3A and 3D). Cell
cycle-related genes were also found to be upregulated in the
early-response cluster 7. The top five GO terms enriched among
the genes upregulated in cluster 7 were all related to cell division
(Figures 3B and 3E). Plotting the average expression of G1/S and
G2/M genes (Tirosh et al., 2016) revealed an approximate circle
(Figure S4D), presumably reflecting progression along the cell
cycle. Cells from Cluster 3 and Cluster 7 were separated by
G1/S and G2/M phase scores, indicating they are in different
phases of the cell cycle (Figure S4D). To measure the prolifera-
tive activity of microglia, we injected CK and CK-p25 mice with
the thymidine analog, 5-ethynyl-20-deoxyuridine (EdU), every
second day during the first 2 weeks after p25 induction. Fluores-
cent labeling of EdU followed by flow cytometry analysis using
the microglia markers CD11b and CD45 revealed that 3% of
the microglia from CK control mice had incorporated EdU, in
contrast to the significantly larger fraction (22%) seen in CK-
p25 mice (Figure S4E). To test whether this increased prolifera-
tive activity is reflected in higher microglia density, we performed
immunostaining of hippocampal sections and imaged across the
major subregions in CK and CK-p25 mice. In 1wk CK-p25 mice,
we observed that the density of Iba1-positive microglia was un-
changed in the CA1 subregion (Figure S4F) but already signifi-
cantly increased in CA3 (Figure S4G) and dentate gyrus (Figures
S4H and S4K). In 2wk and 6wk CK-p25 mice, microglia density
was significantly increased in all three hippocampal subregions
examined (Figures S4F–S4K). These findings are consistent
with our analysis of single-cell RNA sequencing (Figures 3A,
3B, 3D, and 3E) and EdU incorporation data (Figure S4E), indi-
cating that hippocampal microglia show increased proliferation
early in the response to neurodegeneration.
Among the genes upregulated in the late-response cluster 6,
wedidnot seecell cyclegenesbut rather sawover-representation
of immune response-related genes instead (Figure 3C). The
top five GO terms included immune system process, defense
response to virus, and innate immune response (Figures 3C and
3F). The list of genes included those encoding major histocom-
patibility complex (MHC) class 1 (H2-D1, H2-Q5) and class II370 Cell Reports 21, 366–380, October 10, 2017(H2-Aa, H2-Ab1, Cd74) components. We also identified many
interferon response genes (Ifitm3, Irf7) and genes associated
with the GO term ‘‘defense response to virus’’ (Oas1a, Rsad2,
Zbp1). Bindingmotifs of the interferon-regulatory factor (IRF) fam-
ily were significantly enriched within a 1 kb window around the
transcription start site of genes upregulated in cluster 6, providing
further evidence for an enrichment of interferon response-related
genes in late-response state microglia (Table S5). Overall, these
data indicate that microglia mount a pronounced immune
response during the later stages of neurodegeneration.
Temporally Distinct Transcriptional Dynamics among
Immune Response-Related Genes during Microglia
Activation
To further dissect the gene expression changes underlying
cellular reprogramming of microglia, we analyzed the pairwise
correlations between the expression levels of upregulated genes
(see Experimental Procedures). Hierarchical clustering of the re-
sulting correlation matrix of genes upregulated in the early-
response cluster 3 cells revealed at least two major modules of
co-regulated genes (Figure S5A). GO term enrichment analysis
suggested that these twomodules contained functionally distinct
sets of genes. Whereas genes related to translation, metabolic
processes, and immune response were over-represented in
module 1, genes involved in cell cycle and DNA metabolic pro-
cesseswere over-represented inmodule 2 (Figure S5B). A similar
separation into two functionally distinct modules was observed
for the genes upregulated in the early-response cluster 7 (Fig-
ure S5C). Genes involved in cell cycle andmitosis were over-rep-
resented in module 1, while genes with a role in the immune
response and metabolic processes were over-represented in
module 2 (Figure S5D). Modules of co-regulated genes upregu-
lated in the late-response cluster 6 also contained functionally
distinct sets of genes (Figure S5E). Whereas genes involved in
the immune response were over-represented inmodule 1, genes
related to translation and metabolic processes were over-repre-
sented in module 2 (Figure S5F). Thus, this analysis identified
functionally distinct modules of co-regulated genes in microglia
responding to neurodegeneration. Interestingly, the GO terms
enriched among module 1 genes upregulated in cluster 3 were
also found to be themost highly enriched among the genes upre-
gulated in cluster 6. Indeed, 199 of the 255module 1 genes upre-
gulated in cluster 3were also found to be upregulated in cluster 6,
indicating a partial overlap in the gene expression signatures that
distinguish cells of the early and the late-response cluster from
cells in the healthy brain (data not shown).
To more precisely examine the relationship between the early
and late response of microglia cells, we next focused only on
cluster 3 cells that were isolated from 1wk CK-p25 mice (Fig-
ure 2D). We found that a substantial fraction (191) of the genes
significantly upregulated in late-response cluster 6 cells were
also significantly upregulated (with a certainty of 95%) in CK-
p25 microglia after only 1 week of p25 induction (Figure 4A). Of
the twoearly-response clusters, we focused our analysis on clus-
ter 3 because of relatively higher cell numbers, but a similar over-
lap ingene expression signatures couldbe seen in cluster 7, as 38
of the57module2genesupregulated inCluster 7werealso found
to be upregulated in cluster 6 (data not shown). When we plotted
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Figure 3. Single-Cell Differential Expression Analysis Reveals Hundreds of Genes Regulated during Cellular Reprogramming of Microglia in
Response to Neurodegeneration
(A–C) Bar plots showing the top 5Gene Ontology (GO) terms (biological processes) associated with genes upregulated in (A) cluster 3 comparedwith cluster 2, (B)
cluster 7 compared with cluster 2, and (C) cluster 6 compared with cluster 2.
(D and E) Bar graphs showing the fold change in gene expression of the top upregulated genes associated with the top 10 GO terms in cells of cluster 3 (D) and
cluster 7 (E) compared with cells of cluster 2.
(F) Bar graph showing the fold change in gene expression of selected genes associated with the top 10 GO terms in cells of cluster 6 compared with cells of
cluster 2.
For all panels, error bars show the 95% confidence interval.the fold change of gene expression in 1wk CK-p25 cluster 3
versus the fold change of gene expression in late-response clus-
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Figure 4. Temporally Distinct Transcriptional Dynamics
among Immune Response-Related Genes during Micro-
glia Activation
(A) Scatterplot comparing the fold change in gene expression in
early- and late-response microglia for genes significantly differ-
entially expressed. The genes significantly upregulated (with a
certainty of 95%) in early- and late-response microglia are shown
in orange. All other genes are shown in blue. Definition of early-
response microglia: cells of cluster 3 that were isolated from CK-
p25 mice 1 week after p25 induction (1wk CK-p25). Definition of
late-response microglia: cells of cluster 6.
(B and C) t-SNE plots as shown in Figure 2A. Selected genes
showing early and consistent upregulation (B) and selected genes
exclusively upregulated in the late-response cluster 6 (C) are
shown. Data points are colored by the expression levels of the
genes indicated.
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early-response microglia (Figure 4A). Among the set of 191 early
and consistently upregulated genes, 38 genes were significantly
upregulated with a more stringent cutoff (p < 0.001) in cells of the
early-response cluster 3 (data not shown). This latter set included
genes encoding lysosomal cysteine proteases (Ctsb, Ctsz),
the cysteine protease inhibitor Cst7, the inflammatory cytokine
Mif, chemokines (Ccl12, Ccl3, Ccl4, Cxcl16), other immune
response-related genes (Tlr2, Lilrb4), and genes involved in
glycolysis (Pkm, Pgk1, Gapdh, Pgam1). These genes were also
significantly upregulated (with a certainty of 95%) in themicroglia
of the early-response cluster 7 (Table S4). The set of genes that
was exclusively upregulated during the later stages of neurode-
generation included many genes we had identified to be more
than 10-fold upregulated in the cells of cluster 6, including com-
plement components (C3, C4b, and Cfb), MHC class 1 (H2-D1,
H2-Q4, H2-Q5) and class II (H2-Aa, H2-Ab1, Cd74) components,
genes involved in the interferon response (Ifitm3, Irf7) and genes
associated with the GO term ‘‘defense response to virus’’
(OaS1a, Rsad2, Zbp1). Overall, our analysis revealed a dichot-
omy in the transcriptional dynamics among genes significantly
upregulated in late-responsemicroglia andpoint to thepossibility
that the early-response cluster represents a transient, intermedi-
ate activation state of microglia.
Next, we explored the transcriptional dynamics of these genes
during the time course of neurodegeneration in individual micro-
glia. This analysis provided evidence that a subset of immune
response-related genes in late-response cluster 6, including
chemokines Ccl3, Ccl4, and Cxcl16 and inflammatory cytokine
Mif, were already upregulated in a subset of microglia 1 week
after p25 induction (Figure 4B). In contrast, the expression of
other immune-related genes, such as H2-D1, Axl, Apoe, and
Lgals3bp, was increased in the majority of cells of the late-
response cluster 6 but not in 1wk CK-p25 Cluster 3 cells (Fig-
ure 4C). In summary, our analysis of transcriptional dynamics
during disease progression uncovered temporally distinct sub-
sets of immune response-related genes during microglia activa-
tion in a neurodegenerative context.
Heterogeneous Late Response of Microglia to
Neurodegeneration Is Typified by Different Modules of
Co-regulated Genes
We next focused solely on the transcriptional dynamics in late-
response microglia and discovered small subsets of single cells
characterized by upregulation of specific gene sets, such as
antiviral and interferon response genes (Figure 5A) and compo-
nents of the MHC class II pathway (Figure 5B). To quantify the
activation of these two gene sets within individual cells, we
computed a module score as previously described (Shalek
et al., 2014; see Experimental Procedures). We computed the
module scores for a set of 132 co-regulated antiviral and inter-
feron response genes. Most 2wk and 6wk CK-p25 microgliaFigure 5. Heterogeneous Late Response to Neurodegeneration of Mic
t-SNE plots as shown in Figure 2A.
(A) Data points are colored by the expression level of selected antiviral and inter
(B) Data points are colored by the expression level of the genes encoding MHC
(C) Scatterplots showing the correlation of the expression level of MHC class II re
Actb, Gapdh, and Rpl13 across the cells of cluster 6.
374 Cell Reports 21, 366–380, October 10, 2017showed activation of the antiviral and interferon response
gene expression module (Figures 6A and 6C). However, there
was substantial variation across individual cells, with a small
subset of cells exhibiting a fold induction module score that
was at least an order of magnitude higher than the average (Fig-
ures 6A and 6C). We also computed the module scores for the
four genes encoding components of MHC class II. Whereas
some 2wk and 6wk CK-p25 microglia showed no detectable
activation of the MHC class II module, other cells exhibited a
fold induction value at least an order of magnitude higher than
the average (Figures 6B and 6D). In contrast to the variability
seen in antiviral and interferon response genes and MHC class
II components, the induction scores of another module of co-
regulated genes, containing mainly ribosomal protein-encoding
genes exhibited a much narrower distribution (Figure 6E). More-
over, for the MHC class II components, although the expression
of these genes was highly variable between cells, it was tightly
correlated within individual cells and the expression of the
MHC class II-related gene CD74 was not correlated with the
expression of the housekeeping genes Actb, Gapdh, and
Rpl13 (Figure 5C). These observations indicate that the exten-
sive variability in the expression of MHC class II components
measured across cells reflects true biological differences, rather
than technical noise inherent to single-cell RNA sequencing ex-
periments. There was no correlation observed between the in-
duction of the antiviral and interferon response module and
the MHC class II module, indicating that the cells expressing
high levels of antiviral and interferon response genes and the
cells expressing high levels of MHC class II genes are not
necessarily identical (Figure 6F). Thus, these data indicate that
there are at least two distinct reactive microglia phenotypes in
neurodegeneration.
To corroborate the observed heterogeneity among microglia
with an alternative approach, we performed immunostaining of
hippocampal sections from CK and CK-p25 mice. To examine
the expression of co-regulated antiviral and interferon response
genes, we stained the sections with antibodies recognizing the
protein products of Cd40 and Cd69 and for the microglia marker
Iba1. We observed an increase in the number of CD40-express-
ing cells in all three hippocampal subregions of 6wk CK-p25
mice compared with CK control mice (dentate gyrus: Figures
7A, 7C, and S6A; CA1 and CA3: Figure S6B). Importantly, the im-
munostaining revealed that only a subset of the Iba1-positive
cells detectably express CD40 (dentate gyrus: Figures 7A, 7C,
and S6A; CA1 and CA3: Figure S6B). Similarly, we found an
increased number of CD69-positive cells in all three hippocam-
pal subregions of CK-p25 mice 6 weeks after p25 induction
compared with CK control mice (dentate gyrus: Figures 7B,
7D, and S6C; CA1 and CA3: Figure S6D). However, again, only
a subset of Iba1-positive cells detectably expressed CD69 in
CK-p25 mice (dentate gyrus: Figures 7D and S6C; CA1 androglia Is Typified by Different Modules of Co-regulated Genes
feron response genes as indicated.
class II components as indicated.
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CA3: Figure S6D). We next stained the sections with an antibody
recognizing the MHC class II component CD74. In the hippo-
campus of CK control mice, only very few cells expressing the
MHC class II component CD74 were detected (dentate gyrus:
Figures 7E, 7F, and S6E; CA1 and CA3: Figure S6F). In contrast,
the number of CD74-positive cells was dramatically increased in
the hippocampus of CK-p25 mice 6 weeks after p25 induction
(dentate gyrus: Figures 7E, 7F, and S6E; CA1 and CA3: Fig-
ure S6F). Importantly, the overall proportion of CD74-expressing
microglia was limited to only a subset of cells, confirming the het-
erogeneity of the hippocampal microglia population in the
response to neurodegeneration (dentate gyrus: Figures 7E, 7F,
and S6E; CA1 and CA3: Figure S6F). Taken together, our immu-
nostaining data show that the expression of two components of
a module of co-regulated antiviral and interferon response genes
(CD69 and CD40) as well as the MHC class II component CD74
are strongly upregulated in subsets ofmicroglia in the hippocam-
pus of CK-p25. Thus, our immunostaining data confirm a previ-
ously unobserved heterogeneity in the response of microglia to
neurodegeneration.
Gene Sets Induced in the CK-p25 Mouse Model of
Neurodegeneration Also Tend to Be Upregulated in
Microglia of Aged Human Individuals
Finally, we wondered whether the gene sets induced in the CK-
p25 mouse model of neurodegeneration might also be relevant
for the biology of human microglia. To this end, we compared
our data with a recently published transcriptomic analysis of
purified human cortical microglia (Galatro et al., 2017). Specif-
ically, we asked whether the gene sets induced in the CK-p25
mouse model of neurodegeneration also tend to be upregu-
lated in microglia of aged human individuals compared with mi-
croglia of younger individuals. Indeed, we observed that the
expression of gene sets that are human orthologs of the genes
significantly upregulated in clusters 3, 6, and 7 was positively
correlated with age (Figures S7A, S7C, and S7E). In contrast,
the expression of genes downregulated in clusters 3, 6, and 7
was not significantly correlated with age (Figures S7B, S7D,
and S7F). We also found that the expression of human ortho-
logs of the modules of co-regulated antiviral and interferon
response genes and MHC class II components was positively
correlated with age (Figures S7G and S7H). Specifically, the
antiviral and interferon response genes Isg15, Oasl, Ifitm3,
Irf7, and Ifi30 were found among the genes most significantly
correlated with age in human microglia (Table S6). Thus, these
data indicate that the gene sets induced in the CK-p25 mouse
model of neurodegeneration also tend to be upregulated in mi-
croglia of aged human individuals.Figure 6. Two Distinct Reactive Microglia Phenotypes in Late Respons
(A and B) Histograms showing the distribution of the weighted fold induction of a m
complex-related genes (B) across the cells of the groups indicated.
(C and D) t-SNE plots as shown in Figure 2A. Data points are colored by the weigh
and (D) a module of four MHC class II complex-related genes.
(E) Histograms showing the distribution of the weighted fold induction of a modu
across the cells of the groups indicated.
(F) Scatterplot showing the correlation between the induction of the antiviral and in
from CK-p25 mice 2 and 6 weeks after p25 induction.
376 Cell Reports 21, 366–380, October 10, 2017DISCUSSION
In this study we comprehensively surveyed the transcriptome of
microglia cells as they progressed from healthy to neurodegen-
eration states in the brain at single-cell resolution. We found a
remarkable phenotypic heterogeneity of microglia: from early-
response states, characterized by marked proliferation, to late-
response states of mounting immune response. In this latter
group, we discovered a further heterogeneity that was typified
by functionally distinct modules of co-regulated genes.
Temporal Changes of Microglia Response to
Neurodegeneration
We were interested to decipher the initial response of microglia
to insult and to track the temporal changes of these cells over
the course of neurodegeneration. We used the CK-p25 mouse
model of severe neurodegeneration, as it displays key patholog-
ical hallmarks of AD in a temporally predictable manner, to
study the response of microglia at fine temporal- and single-
cell resolution. Our single-cell RNA sequencing analysis identi-
fied two neurodegeneration-associated microglia cell states
that are distinct from the microglia state in the healthy brain.
Importantly, we found that microglia isolated at an early stage
of neurodegeneration (early-response microglia cell state) are
distinct from microglia isolated at a late stage of neurodegener-
ation (late-response microglia cell state). However, the early-
and late-response microglia cell states are not completely unre-
lated, as we found that a substantial fraction of genes that are
upregulated in late-response microglia are already increased
in early-response microglia. Moreover, 1wk CK-p25 cells were
distributed across homeostatic microglia cluster 2 and early-
response cluster 3, and share characteristics with both micro-
glia in the healthy brain and fully activated microglia at the later
stages of neurodegeneration. These observations suggest that
the early-response microglia cell state represents a transient in-
termediate activation state that constitutes part of the trajectory
of cellular reprogramming of homeostatic microglia in response
to neurodegeneration.
Although we cannot exclude the possibility that some of the
cells analyzed are peripheral immune cells, our data suggest
that the large majority of cells examined are microglia cells. First,
the large majority of cells analyzed expressed microglia marker
genes but not peripheral immune cells signature genes (Figures
1C and S1K). Second, only a very small fraction of cells ex-
pressed high levels of CD45, a characteristic of peripheral im-
mune cells (Figure S2). Third, t-SNE analysis revealed two small
clusters (clusters 4 and 5) that expressed peripheral immune cell
marker genes, showing that our methods have sufficient powere to Neurodegeneration
odule of 132 antiviral and interferon response genes (A) and four MHC class II
ted fold induction of (C) a module of 132 antiviral and interferon response genes
le of co-regulated genes mainly containing ribosomal protein-encoding genes
terferon responsemodule and theMHCclass II module across the cells isolated
(legend on next page)
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to detect the subtle differences in gene expression between mi-
croglia and peripheral immune cells (Figure 2A).
Microglia Proliferate and Increase the Expression of a
Small Set of Cytokines at an Early Stage of
Neurodegeneration
Our previous study had revealed an increased level of transcripts
encoding immune response-related genes in hippocampal tis-
sue of CK-p25 mice (Gjoneska et al., 2015). However, it was un-
clear whether this increase was due to gene expression changes
in microglia or to an expansion of the microglia population as a
result of proliferation. Our data clearly demonstrate that micro-
glia respond to neurodegeneration with both a dramatic reprog-
ramming of their transcriptome and increased proliferation. We
identified a small set of cytokines, including the pro-inflamma-
tory cytokines MIF and TNF, that are upregulated in the late-
response microglia cell state but already show upregulation
1 week after p25 induction. Interestingly, the pro-inflammatory
cytokine TNF has recently been identified as one of the factors
that are necessary and sufficient to induce a neurotoxic astro-
cyte cell state (Liddelow et al., 2017). This raises the possibility
that early-response microglia may contribute to the initiation of
a cascade that ultimately leads to neuronal death during the later
stages of neurodegeneration. Given the pleiotropic effects of
TNF reported (Probert, 2015), it is possible that increased
expression of TNF in microglia serves multiple distinct functions
that remain to be explored.
Two Distinct Reactive Microglia Phenotypes in
Neurodegeneration
We discovered small subsets of microglia in the hippocampus of
CK-p25 mice late in neurodegeneration typified by strong upre-
gulated expression of selected gene sets, such as antiviral and
interferon response genes and MHC class II components. Inter-
estingly, these two subsets do not overlap entirely, indicating that
not only are there at least two distinct reactive microglia pheno-
types in the heterogeneous cell population but that there are
likely multiple triggers of microglia activation. Interestingly, we
detectedmany genes that are induced by type I interferon among
the module of co-regulated antiviral and interferon response
genes. In contrast, MHC class II genes have been shown to be
induced by interferon-gamma (type II interferon) (O’Keefe et al.,
2001). This raises the intriguing possibility that the two distinct
subsets of reactive microglia we observed in CK-p25 mice could
reflect exposure to type I interferon versus type II interferon.
What might be the trigger to induce expression of the co-regu-
lated antiviral and interferon response gene module? We foundFigure 7. Immunostaining Reveals Heterogeneous Late Response of M
Immunostaining in the dentate gyrus of CK-p25 mice 6 weeks after p25 inductio
(A) Immunohistochemistry with anti-CD40 (red) and anti-Iba1 (white) antibodies. C
right.
(B) Immunohistochemistry with anti-CD69 (red) and anti-Iba1 (white) antibodies.
(C–E) Quantification of the CD40 (C), CD69 (D), MHC2 (E), and Iba1 immunostaini
MHC2, respectively.
(F) Immunohistochemistry with anti-GFP (green), anti-CD74 (MHC2, red), and an
staining in the dentate gyrus of seven CK mice and four CK-p25 mice, with two
Error bars show SEM. **p < 0.01; ***p < 0.001.
378 Cell Reports 21, 366–380, October 10, 2017that a subset of microglia with activated type I interferon pathway
are in close proximity to neurons harboring DNA damage (Fig-
ures S6G and S6H). It is well established that DNA damage
can lead to the induction of type 1 interferons (Ha¨rtlova et al.,
2015). Thus, DNA damage might be one factor that contributes
to the induction of antiviral and interferon response genes in mi-
croglia. Consistent with this idea, we found that the module of
co-regulated antiviral and interferon response genes was signif-
icantly upregulated in microglia of the DNA-repair deficient
mouse model Ercc1D/- compared with wild-type control mice
(Figures S7I and S7J).
In the peripheral immune system, MHC class II molecules are
responsible for presenting peptides derived from extracellular
pathogens to T cells and are expressed by a subset of anti-
gen-presenting cells, such as macrophages, dendritic cells,
and B cells (Ting and Trowsdale, 2002). Whether the subset of
microglia expressing high levels of MHC class II molecules
indeed functions as antigen-presenting cells is an intriguing hy-
pothesis that remains to be addressed. Alternatively, MHC class
II molecules could serve a T cell-independent function in micro-
glia. Supporting this idea, it has been shown that the presence of
MHC class II molecules exacerbated both neurodegenerative
symptoms and neuropathology in murine globoid leukodystro-
phy, most likely in a T cell-independent manner (Matsushima
et al., 1994).
Recently, Keren-Shaul et al. (2017) reported the identification
of a microglia type associated with neurodegenerative diseases,
termed disease-associatedmicroglia (DAM). The authors carried
out single-cell RNA sequencing on microglia isolated from a
mouse model of AD that expresses five human familial AD
gene mutations (5XFAD) and from a mouse model of amyotro-
phic lateral sclerosis (mSOD1 [G93A] mice). The DAM microglia
phenotype was observed only in the 5XFAD and mSOD1 (G93A)
mice but not in the corresponding wild-type mice. Using a
different mouse model of neurodegeneration (CK-p25), we iden-
tified a microglia cell state that was almost exclusively observed
at the later stages of disease progression (late-response micro-
glia). Interestingly, late-response microglia express increased
levels of many genes that were also observed to be upregulated
in DAM (e.g., Cd9, Itgax, Clec7a, Cd63, Spp1, Fth1, Axl, Lpl,
Cst7, Ctsb, Apoe). Of the 278 genes significantly upregulated
in DAM, 202 genes were also significantly upregulated in late-
response microglia, suggesting a substantial similarity between
the expression profiles of DAM and late-response microglia.
This observation is consistent with the idea that the DAM pro-
grammay be a primed set of genes that is expressed in response
to varied conditions of altered homeostasis (Keren-Shaul et al.,icroglia to Neurodegeneration
n.
ells indicated with blue and red arrows are shown at higher magnification on the
ng. Values are percentages of Iba1-positive cells expressing CD40, CD69, and
ti-Iba1 (white) antibodies. For all graphs, quantification is based on immuno-
sections per animal.
2017). However, we found that many antiviral and interferon
response genes were significantly upregulated in late-response
microglia but not in DAM, suggesting that there may also be po-
tential differences between these two microglia cell states.
Keren-Shaul et al. (2017) proposed that DAM are generated
through a two-step activation process. Homeostatic microglia
first transition to an intermediate stage (stage 1 DAM) in a
Trem2-independent manner, followed by a second, Trem2-
dependent, transition to stage 2 DAM. We saw significant differ-
ences in the expression of both stage 1 DAM and stage 2 DAM
characteristic genes in late-response microglia but much less
so in early-response microglia (Figure S7K). This observation
may indicate that early-response microglia are in an even more
naive activation state than stage 1 DAM. Whether the induction
of a DAM-like expression program in microglia of the CK-p25
model of neurodegeneration is protective, neutral, or deleterious
remains to be determined.
In summary, our work identified previously unobserved het-
erogeneity in the response of microglia to neurodegeneration,
including the discovery of microglia cell states, and uncovered
transcriptional programs underlying the trajectory of cellular re-
programming of microglia in response to neurodegeneration.
Our analysis also indicates thatmany of the gene expression reg-
ulatory events identified in our mouse model are conserved in
aged human microglia. Thus, these insights into the molecular
programs underlying microglia activation may pave the way for
designing rational and efficient strategies to treat AD and other
neurodegenerative diseases.EXPERIMENTAL PROCEDURES
Animals
All animal work was approved by the Committee for Animal Care of the Division
of Comparative Medicine at the Massachusetts Institute of Technology.
Isolation of Microglia from the Hippocampus
Hippocampal tissue was enzymatically digested using the Neural Tissue
Dissociation Kit (P) (catalog number 130-092-628; Miltenyi Biotec) according
to the manufacturer’s protocol, with minor modifications. The resulting cell
suspension was then stained using allophycocyanin (APC)-conjugated
CD11bmouse cloneM1/70.15.11.5 (130-098-088;Miltenyi Biotec) and phyco-
erythrin (PE)-conjugated CD45 antibody (553081; BD PharMingen) according
to the manufacturer’s (Miltenyi Biotec) recommendations. FACS was then
used to purify CD11b and CD45 positive microglial cells.
Single-Cell RNA Sequencing Library Preparation
Single-cell RNA sequencing libraries were generated on the basis of the
SMART-Seq2 protocol (Picelli et al., 2014) with minor modifications. Libraries
were tagmented using the Nextera XT DNA Library Preparation Kit (catalog
number FC-131-1096; Illumina) and the Nextera XT Index Kit version 2 Sets
A, B, C, and D according to the manufacturer’s instructions with minor modi-
fications. Specifically, reactions were run at one fourth the recommended vol-
ume, the tagmentation step was extended to 10 min, and the extension time
during the PCR step was increased from 30 s to 60 s.
Click-iT Plus EdU Cell Proliferation Assay
Animals were intraperitoneally injected with 50 mg/kg EdU every second day
during the first 2 weeks after p25 induction. Two weeks after p25 induction,
the animals were transcardially perfused with ice-cold PBS, and microglia
were isolated using the Neural Tissue Dissociation Kit (P) as described above.
EdU incorporation was then detected using the Click-iT Plus EdU Pacific BlueFlow Cytometry Assay Kit (catalog number C10636; Thermo Fisher Scientfic)
according to the manufacturer’s instructions.
Immunohistochemistry
Immunohistochemistry experiments were performed as described previously
(Iaccarino et al., 2016).
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